Physician profile
Brad Scott Webb
NPI 1518900562
$3,545.35
in general payments reported to CMS, 2019-2025
15 companies · $1,232 in 2025
The $1,232 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.01 · 2020: $36.58 · 2021: $71.11 · 2022: $47.61 · 2023: $53.76 · 2024: $2,019 · 2025: $1,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,452 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,451.79 |
| Food and Beverage | $852.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,140.76 | 2023-2025 | Infinity, Prostep, Inbone |
| Smith+Nephew, INC. | $131.49 | 2019-2025 | Grafix Pl |
| Abbott Laboratories | $54.50 | 2021 | |
| Paragon 28, INC. | $35.64 | 2024-2025 | Gorilla |
| Solventum Corporation | $25.52 | 2025 | Snap, Activ.A.C., 3m Cavilon |
| Misonix INC | $24.24 | 2020 | |
| Merck Sharp & Dohme LLC | $22.70 | 2019 | |
| Nevro Corp. | $20.82 | 2022 | |
| Alfasigma USA, INC. | $16.61 | 2021 | |
| Abbvie INC. | $15.14 | 2022 | |
| Podimetrics, INC. | $14.40 | 2025 | Smartmat |
| Convatec INC. | $12.34 | 2020 | |
| Boston Scientific Corporation | $11.65 | 2022 | |
| Integra Lifesciences Corporation | $10.80 | 2019 | |
| Organogenesis INC. | $8.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.